111, Inc. Hosts Hua Medication Launches First Official Flagship Retailer

111, Inc. Hosts Hua Medication Launches First Official Flagship Retailer



Feb. 16, 2023

/PRNewswire/ — On

February 15, 2023

, 111, Inc. (“111” or the “Firm”) (NASDAQ: YI), a number one tech-enabled healthcare platform firm in


, introduced that throughout the HuaTangNing® Market Launch for Progressive Commerce Cooperation, Dr.

Yu Gang

, Co-founder and Govt Chairman of 111, and Dr.

Chen Li

, Founder and CEO of Hua Medication (HKEx inventory code: 2552.HK), collectively unveiled the plaque of Hua Medication’s first official on-line flagship retailer on 111.

111 is dedicated to digitally connecting sufferers with drugs and healthcare companies, aspiring to construct itself into an built-in on-line and offline healthcare platform. The official flagship retailer launched by Hua Medication on 111 will function an official window to showcase the excellent model picture of Hua Medication and an vital platform for Hua Medication to raised serve each sufferers and medical doctors. For its half, 111 will additional assist Hua Medication broaden its business format, broaden its drug provide and distribution channels, and discover modern and diversified provide service modes. The official flagship retailer will present sufferers with Hua Medication’s modern remedy ideas, perform affected person schooling on drug security and different subjects, and launch the most recent information from Hua Medication.


Yu Gang

, Co-founder and Govt Chairman of 111, stated: “Hua Medication is a pacesetter in modern drug analysis and commercialization in


. Over time, it has devoted itself to the analysis and improvement of authentic medication. HuaTangNing®,

a first-in-class drug of its type

, is from Hua Medication. The official opening of its flagship retailer on 111 is a well timed and modern measure taken by a Chinese language modern pharmaceutical firm to embrace the Web. On the identical time, it additionally marks a key milestone for 111 and Hua Medication within the exploration of on-line cooperation. 111 will work with Hua Medication to make cutting-edge modern medication extra accessible for diabetes sufferers, empower diabetes remedy in addition to affected person administration, and contribute worth to society.”


Li Chen

, Founder and CEO of Hua Medication, stated: “111 is a benchmark participant in


Web drugs and healthcare trade, geared up with main digital know-how and good provide chain. We’re very a lot trying ahead to Hua Medication’s cooperation with 111, as we offer modern options of well being administration and medical companies by means of the net flagship retailer. Sooner or later, Hua Medication will proceed to discover partnership alternatives with Web channels to profit extra diabetic sufferers.”

About Hua Medication

Hua Medication is an modern drug improvement and commercialization firm primarily based in

Shanghai, China

, centered on creating novel therapies for sufferers worldwide with unmet medical wants. Primarily based on international sources, Hua Medication groups up with international high-caliber individuals to develop breakthrough applied sciences and merchandise, which contribute a world innovation in diabetes care. As Hua Medication’s cornerstone product (dorzagliatin tablets), concentrating on the glucose sensor, glucokinase, restores glucose sensitivity in T2D sufferers and stabilizes the imbalance of blood glucose ranges in sufferers, it has been authorised by the Nationwide Medical Merchandise Administration (NMPA) of



September 2022

. It may be used alone or together with metformin hydrochloride-tolerated T2D sufferers. For these sufferers with power kidney illness (CKD) and Kind 2 diabetes (i.e., diabetes kidney illness), no dose adjustment is required.

About 111, Inc.

111, Inc. (NASDAQ: YI) (“111” or the “Firm”) is a number one tech-enabled healthcare platform firm dedicated to digitally connecting sufferers with drugs and healthcare companies in


. The Firm supplies shoppers with higher entry to pharmaceutical merchandise and healthcare companies instantly by means of its on-line retail pharmacy, 1 Pharmacy, and not directly by means of its offline digital pharmacy community. The Firm additionally provides on-line healthcare companies by means of its web hospital, 1 Clinic, which supplies shoppers with cost-effective and handy on-line session, digital prescription service, and affected person administration service. As well as, the Firm’s on-line platform, 1 Medication, serves as a one-stop store for pharmacies to supply an enormous choice of pharmaceutical merchandise. With the biggest digital pharmacy community in


, 111 permits offline pharmacies to raised serve their prospects with cloud-based companies. 111 additionally supplies an omni-channel drug commercialization platform to its strategic companions, which incorporates companies corresponding to digital advertising, affected person schooling, information analytics, and pricing monitoring.

For extra data on 111, please go to:



Ahead-Trying Statements

This press launch comprises forward-looking statements. These statements represent “forward-looking” statements inside the which means of Part 21E of the Securities Alternate Act of 1934, as amended, and as outlined within the U.S. Non-public Securities Litigation Reform Act of 1995. These forward-looking statements might be recognized by terminology corresponding to “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “goal,” “assured” and related statements. Amongst different issues, the Enterprise Outlook and quotations from administration on this announcement, in addition to 111’s strategic and operational plans, include forward-looking statements. 111 might also make written or oral forward-looking statements in its periodic studies to the U.S. Securities and Alternate Fee, in its annual report back to shareholders, in press releases and different written supplies and in oral statements made by its officers, administrators or workers to 3rd events. Such statements are primarily based upon administration’s present expectations and present market and working circumstances and relate to occasions that contain recognized or unknown dangers, uncertainties and different elements, all of that are troublesome to foretell and lots of of that are past the Firm’s management. Ahead-looking statements contain inherent dangers, uncertainties and different elements that might trigger precise outcomes to vary materially from these contained in any such statements. Potential dangers and uncertainties embody, however usually are not restricted to, uncertainties as to the Firm’s potential adjust to intensive and evolving regulatory necessities, its potential to compete successfully within the evolving PRC common well being and wellness market, its potential to handle the expansion of its enterprise and enlargement plans, its potential to attain or keep profitability sooner or later, its potential to regulate the dangers related to its pharmaceutical retail and wholesale companies, and the Firm’s potential to fulfill the requirements obligatory to keep up itemizing of its ADSs on the Nasdaq International Market, together with its potential to remedy any non-compliance with Nasdaq’s continued itemizing standards. Additional data relating to these and different dangers, uncertainties or elements is included within the Firm’s filings with the U.S. Securities and Alternate Fee. All data offered on this press launch is as of the date of this press launch, and 111 doesn’t undertake any obligation to replace any forward-looking assertion because of new data, future occasions or in any other case, besides as required underneath relevant legislation.

111, Inc. Hosts Hua Medication Launches First Official Flagship Retailer
View authentic content material:


SOURCE 111, Inc.